A Swedish within-person analysis of 930 intermittent medication users taking 2,524 entrance tests found scores 4.80 points higher during medicated periods after adjustment. This is JAMA Psychiatry 2017, not the alleged 2020 long-term harm study, and it did not measure 20-year college attendance.
This cohort study observed 61 640 individuals with a diagnosis of ADHD from January 1, 2006, to December 31, 2013.
A Swedish within-person analysis of 930 intermittent medication users taking 2,524 entrance tests found scores 4.80 points higher during medicated periods after adjustment. This is JAMA Psychiatry 2017, not the alleged 2020 long-term harm study, and it did not measure 20-year college attendance. Observational within-person design; it does not establish randomized long-term treatment effects.
